Andrew J. Schwab - Director at Skye Bioscience, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SKYE on Nasdaq
All Insider Reports
All Insider Reports

Andrew J. Schwab - trading volume in the past year for Skye Bioscience, Inc.

Holdings reported by Andrew J. Schwab for Skye Bioscience, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8,167,206 $29,483,613 $3.61 21 Aug 2025 By 5AM Ventures VII, L.P.
Common Stock 1,457,064 $4,983,158 $3.42 22 Aug 2025 By 5AM Ventures II, L.P.
Common Stock 57,493 $196,626 $3.42 22 Aug 2025 By 5AM Co-Investors II, L.P.
Stock Option (Right to Buy) 35,000 06 Feb 2026 Direct Common Stock

Transactions reported by Andrew J. Schwab for Skye Bioscience, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.